Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hyperthermia 20Sarcoma 8Uterine Cervical Neoplasms 7Breast Neoplasms 6Rectal Neoplasms 5Prostatic Neoplasms 5Ovarian Neoplasms 5Colonic Neoplasms 5Neoplasm Metastasis 4Head and Neck Neoplasms 4Neoplasms 3Melanoma 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma, Synovial 2Neurofibrosarcoma 2Liver Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Colorectal Neoplasms 2Carcinoma, Ovarian Epithelial 2Unspecified Adult Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1

Interventions

Uterine Myomectomy 1Uterine Artery Embolization 1Salpingectomy 1Gonadotropin-Releasing Hormone 1Diathermy 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pelvic Pain × Diathermy × Clear all
NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
115 enrolled

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡